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permit publication of information
allowing the furtherance of the
research enterprise, there was
nevertheless good reason to
believe that the rapid exploitation
of monoclonal antibodies had
been facilitated by the very fact
that they were not patented.
The success of monoclonal
antibodies did not cause Milstein
to neglect his original interest in
antibody diversity. Some of the
work on antibody production by
myeloma cells was performed in
the hope that these cells would
exhibit ongoing antibody
diversification and therefore
permit analysis of the
diversification process — a line of
approach that was in many ways
ahead of its time.
Furthermore, the hybridoma
technology itself allowed him to
further his original interests. By
establishing hybridomas at
different stages of an immune
response, Milstein and colleagues
were able to chart the mutations
that accumulate in the
immunoglobulin V gene during the
course of the response thereby
providing a detailed description of
antibody affinity maturation.
As the last appointment in his
career, Milstein listed ‘retired
(active) worker’ — an enviable
situation in which he was (with the
assistance of a small group) able
to pursue his research interests
without administrative
responsibilities. And active he
remained until the end.
He was developing new
diagnostic applications of
monoclonal antibodies, was
scheduled to examine a PhD
dissertation on CD1 and had,
within a week of his death,
contributed a manuscript for
publication on antibody
diversification. He certainly
followed the advice that I had been
given when young — ‘Leave the
party while you are still enjoying it’.
The party will obviously continue,
greatly saddened by his absence,
but with its activities and
participants inspired by his
multitude of contributions.
Michael Neuberger is at the Medical
Research Council Laboratory of
Molecular Biology, Hills Road,
Cambridge CB2 2QH, UK.
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What is it? Brain-derived
neurotrophic factor (BDNF) is a
member of the neurotrophin family
of growth factors. It is a basic,
homodimeric, secretory protein
with a molecular mass of ~27 kDa.
Are there related proteins? Yes.
There are three other members of
the neurotrophin family found in
mammals, including nerve growth
factor (NGF), neurotrophin-3
(NT-3) and neurotrophin-4
(NT-4/5). Neurotrophins are similar
in structure and sequence and are
likely derived from a common
ancestral gene. NT-6 and -7 have
been recently found only in fish.
Where is it found? BDNF is
located in specific neuronal
populations at low levels in the
peripheral nervous system (PNS)
and at much higher levels in the
central nervous system (CNS). It is
most highly expressed in the
developing brain, but is still
expressed at lower levels in the
adult brain. Moreover, expression
of BDNF is rapidly and potently
regulated by synaptic activity.
How does BDNF work? BDNF
acts through binding to two
receptors: TrkB and p75. Binding
to the high affinity tyrosine kinase
receptor, TrkB, mediates most of
the neuronal effects of BDNF.
However, BDNF can also bind to a
pan-neurotrophin receptor, p75, to
influence cell death and, perhaps,
to modulate the effects of the
other neurotrophins. BDNF
binding to TrkB induces receptor
dimerization, phosphorylation, and
activation of the intracellular
tyrosine kinase domain. These
events initiate several complex
intracellular signal transduction
cascades.
What is the function of BDNF?
As a classic neurotrophin, BDNF
is believed to be produced in
limited amounts within
postsynaptic neurons where it
serves to match the size of
afferent neuronal populations with
their targets during development.
This traditional view of
neurotrophin function is called the
‘Neurotrophin Hypothesis.’
Are there additional roles for
BDNF? Yes! BDNF influences
almost all aspects of nervous
system development including
neuronal proliferation, neuronal
migration, axon pathfinding,
dendritic growth, synapse
formation and maintenance,
synaptic competition and pruning,
neuronal excitability, both
inhibitory and excitatory synaptic
transmission, long-term plasticity,
and neuronal survival. Perhaps
most exciting, BDNF has been
implicated in mediating the effects
of synaptic activity on neuronal
morphology and connectivity in
the developing brain. Although
BDNF plays many roles in the
developing and adult brain, it
affects only those neurons that
express TrkB or p75.
Can we live without it? No,
although NT-4 can partially
compensate for a lack of BDNF.
BDNF–/– mice show severe
neuronal deficits and early
postnatal death.
Is there anything we don’t know
about BDNF? Yes, a lot. Although
BDNF is implicated in many
aspects of brain development, the
intracellular mechanisms of BDNF
action remain largely unknown.
And it is unclear where and how
BDNF is secreted from neurons.
Finally, the function of BDNF in the
adult brain is almost completely
unexplored.
Where can I find out more?
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